You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

AMMONIA N-13 - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for ammonia n-13 and what is the scope of freedom to operate?

Ammonia n-13 is the generic ingredient in one branded drug marketed by 3d Imaging Drug, Biomedcl Res Fdn, Brigham Womens Hosp, Cardinal Hlth 414, Central Radiopharm, Decatur, Essential Isotopes, Feinstein, Gen Hosp, Ionetix, Johns Hopkins Univ, Kreitchman Pet Ctr, Mcprf, Methodist, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Nukemed, Petnet, Precision Nuclear, Shertech Labs Llc, Sofie, Ucla Biomedical, Ucsf Rodiopharm, Univ Alahama Birm, Univ Tx Md Anderson, Univ Tx Sw Medctr, Univ Wisconsin, Wa Univ Sch Med, and Wisconsin, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.

Twenty suppliers are listed for this compound.

Summary for AMMONIA N-13

US Patents:	0
Tradenames:	1
Applicants:	30
NDAs:	31
Finished Product Suppliers / Packagers:	20
Raw Ingredient (Bulk) Api Vendors:	6
Clinical Trials:	103
Patent Applications:	1,728
What excipients (inactive ingredients) are in AMMONIA N-13?	AMMONIA N-13 excipients list
DailyMed Link:	AMMONIA N-13 at DailyMed

Recent Clinical Trials for AMMONIA N-13

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Khyber Medical College, Peshawar	Phase 4
Cairo University	Phase 3
CBmed Ges.m.b.H.	Phase 4

See all AMMONIA N-13 clinical trials

Pharmacology for AMMONIA N-13

Drug Class	Radioactive Diagnostic Agent
Mechanism of Action	Radiopharmaceutical Activity

US Patents and Regulatory Information for AMMONIA N-13

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Johns Hopkins Univ	AMMONIA N 13	ammonia n-13	INJECTABLE;INTRAVENOUS	204514-001	Aug 19, 2014	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Univ Wisconsin	AMMONIA N 13	ammonia n-13	INJECTABLE;INTRAVENOUS	211740-001	Sep 9, 2020	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Univ Tx Sw Medctr	AMMONIA N 13	ammonia n-13	INJECTABLE;INTRAVENOUS	209507-001	Nov 1, 2019	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Univ Tx Md Anderson	AMMONIA N 13	ammonia n-13	INJECTABLE;INTRAVENOUS	203933-001	Jun 27, 2014		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.